CIViC Compass
Research use only — not FDA-cleared, not medical advice. Always consult FDA-approved labeling and a qualified clinician.
Home/Biomarker

NPM1 mutation (relapsed/refractory AML)

Gene: NPM1 · Type: mutation

Indications: Acute myeloid leukemia

Linked CIViC Profile: NPM1 MUTATION

Evidence Level Distribution

Level B: 3
LevelTypeDirectionSignificanceDiseaseDrugsRating
BDiagnosticSupportsPositiveAcute Myeloid Leukemia With Mutated NPM14
BDiagnosticSupportsPositiveAcute Myeloid Leukemia With Mutated NPM13
BDiagnosticSupportsPositiveAcute Myeloid Leukemia With Mutated NPM13